Detalhe da pesquisa
1.
A systematic review on mutation markers for bladder cancer diagnosis in urine.
BJU Int
; 127(1): 12-27, 2021 01.
Artigo
Inglês
| MEDLINE | ID: mdl-32539176
2.
Second TURB, restaging TURB or repeat TURB in primary T1 non-muscle invasive bladder cancer: impact on prognosis?
Int Urol Nephrol
; 56(4): 1323-1333, 2024 Apr.
Artigo
Inglês
| MEDLINE | ID: mdl-37980689
3.
Real-time analysis of the cancer genome and fragmentome from plasma and urine cell-free DNA using nanopore sequencing.
EMBO Mol Med
; 15(12): e17282, 2023 Dec 07.
Artigo
Inglês
| MEDLINE | ID: mdl-37942753
4.
Prognosis of Primary Papillary Ta Grade 3 Bladder Cancer in the Non-muscle-invasive Spectrum.
Eur Urol Oncol
; 6(2): 214-221, 2023 04.
Artigo
Inglês
| MEDLINE | ID: mdl-36670042
5.
Trial-based Cost-effectiveness Analysis of an Immediate Postoperative Mitomycin C Instillation in Patients with Non-muscle-invasive Bladder Cancer.
Eur Urol Open Sci
; 37: 7-13, 2022 Mar.
Artigo
Inglês
| MEDLINE | ID: mdl-35243387
6.
Bladder cancer detection in urine using DNA methylation markers: a technical and prospective preclinical validation.
Clin Epigenetics
; 14(1): 19, 2022 02 05.
Artigo
Inglês
| MEDLINE | ID: mdl-35123558
7.
T1G1 Bladder Cancer: Prognosis for this Rare Pathological Diagnosis Within the Non-muscle-invasive Bladder Cancer Spectrum.
Eur Urol Focus
; 8(6): 1627-1634, 2022 11.
Artigo
Inglês
| MEDLINE | ID: mdl-35577750
8.
The Origin of Tumor DNA in Urine of Urogenital Cancer Patients: Local Shedding and Transrenal Excretion.
Cancers (Basel)
; 13(3)2021 Jan 31.
Artigo
Inglês
| MEDLINE | ID: mdl-33572525
9.
Prognostic Value of the WHO1973 and WHO2004/2016 Classification Systems for Grade in Primary Ta/T1 Non-muscle-invasive Bladder Cancer: A Multicenter European Association of Urology Non-muscle-invasive Bladder Cancer Guidelines Panel Study.
Eur Urol Oncol
; 4(2): 182-191, 2021 04.
Artigo
Inglês
| MEDLINE | ID: mdl-33423944
10.
European Association of Urology (EAU) Prognostic Factor Risk Groups for Non-muscle-invasive Bladder Cancer (NMIBC) Incorporating the WHO 2004/2016 and WHO 1973 Classification Systems for Grade: An Update from the EAU NMIBC Guidelines Panel.
Eur Urol
; 79(4): 480-488, 2021 04.
Artigo
Inglês
| MEDLINE | ID: mdl-33419683
11.
Comparative Analysis of Urine Fractions for Optimal Bladder Cancer Detection Using DNA Methylation Markers.
Cancers (Basel)
; 12(4)2020 Apr 02.
Artigo
Inglês
| MEDLINE | ID: mdl-32252299
12.
Papillary urothelial neoplasm of low malignant potential (PUN-LMP): Still a meaningful histo-pathological grade category for Ta, noninvasive bladder tumors in 2019?
Urol Oncol
; 38(5): 440-448, 2020 05.
Artigo
Inglês
| MEDLINE | ID: mdl-31704141
13.
Objectifying grade in Ta-T1 urothelial carcinomas of the bladder using proliferative and quantitative markers: A multicentre study in 310 bladder tumors.
Urol Oncol
; 37(8): 530.e1-530.e8, 2019 08.
Artigo
Inglês
| MEDLINE | ID: mdl-30935844
14.
Erratum to "European Association of Urology (EAU) Prognostic Factor Risk Groups for Non-muscle-invasive Bladder Cancer (NMIBC) Incorporating the WHO 2004/2016 and WHO 1973 Classification Systems for Grade: An Update from the EAU NMIBC Guidelines Panel" [Eur. Urol. 79(4) (2021) 480-488].
Eur Urol
; 83(5): e140-e141, 2023 May.
Artigo
Inglês
| MEDLINE | ID: mdl-36841687